Scientists uncover a genetic switch that turns immune responses on and off

Nov 01, 2010

Scientists are keeping their eye on a new discovery published in the November 2011 print issue of the FASEB Journal that explains what causes some genes to go out of control. Scientists have identified a "cellular switch," called eye transformer, that controls the flow of information from chemical signals outside of the cell to genes in the cell nucleus. This study demonstrates that when eye transformer is turned off, the information pathway it controls (the "JAK/STAT pathway") hyper-activates. Because this pathway exists in humans and is involved in many conditions such as cancer, severe immune deficiencies, autoimmune diseases, and allergies, this discovery reveals a new and potentially important drug target for these conditions.

"We hope that our study will open new horizons for researchers studying mammalian JAK/STAT signaling which eventually leads to better understanding how mammalian JAK/STAT signaling is regulated," said Mika Rämet, Ph.D., co-author of the study from the Institute of Medical Technology at the University of Tampere in Finland. "We hope that this information can be then used in developing better treatments for diseases that are influenced by malfunctioning JAK/STAT signaling."

To make this discovery, Rämet and colleagues "silenced" all of the fruit fly one by one using RNAi-based screening methods in cultured Drosophila (fruit fly) cells and then analyzed which genes were important for JAK/STAT signaling. They identified five novel regulators, one of which was a negative regulator of eye transformer that proved to negatively regulate the JAK/STAT response during microbial challenge. Further research showed that suppression of eye transformer expression in the eyes of fruit flies by in vivo RNAi causes hyper-activation of JAK/STAT signaling indicated by drastic eye overgrowth when JAK/STAT signaling was activated.

"We tend to treat immune diseases after the inflammation switch has been turned on," said Gerald Weissmann, M.D., Editor-in-Chief of the and a past president of the American College of Rheumatology. "This study sheds new light on how we might to control diseases like rheumatoid arthritis or lupus by keeping our hands on the switch."

Explore further: Mutations from Mars: Researchers explain why genetic fertility problems can persist in a population

More information: Jenni Kallio, Henna Myllymäki, Juha Grönholm, Morag Armstrong, Leena-Maija Vanha-aho, Leena Mäkinen, Olli Silvennoinen, Susanna Valanne, and Mika Rämet
Eye transformer is a negative regulator of Drosophila JAK/STAT signaling. FASEB J. 2010 24: 4467-4479. DOI: 10.1096/fj.10-162784

add to favorites email to friend print save as pdf

Related Stories

Researchers make stem cells from developing sperm

Aug 06, 2009

The promise of stem cell therapy may lie in uncovering how adult cells revert back into a primordial, stem cell state, whose fate is yet to be determined. Now, cell scientists at the Johns Hopkins University School of Medicine ...

If you think cancer genes are simple, you don't know JAK

Sep 17, 2007

Cancer-causing genes can work in more powerful and sneaky ways than have been realized. Scientists have shown that a gene named JAK that is closely related to a common cancer-causing gene in people tips the scales toward ...

Recommended for you

Gene research targets scarring process

Jul 28, 2014

Scientists have identified three genes that may be the key to preventing scar formation after burn injury, and even healing existing scars.

Researchers find new mechanism for neurodegeneration

Jul 24, 2014

A research team led by Jackson Laboratory Professor and Howard Hughes Investigator Susan Ackerman, Ph.D., have pinpointed a surprising mechanism behind neurodegeneration in mice, one that involves a defect in a key component ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

KitchenDancer
not rated yet Dec 04, 2010
It's a detail, but the summary for this article should read that the study was published in November 2010, not November 2011.